MARIMED INC.·4

Apr 3, 5:03 PM ET

Levine Jon R 4

Research Summary

AI-generated summary

Updated

Marimed (MRMD) 10% Owner Jon R Levine Vests RSUs

What Happened

  • Jon R. Levine, a reported 10% owner of Marimed, had 11,518 restricted stock units (RSUs convert to common stock 1-for-1) vest/convert into 11,518 shares on April 2, 2026. Of those shares, 3,992 were withheld by the issuer to satisfy tax withholding obligations at $0.07 per share, totaling $276. The net shares delivered to Levine were 7,526 (11,518 − 3,992).
  • The filing shows the conversion/exercise of the RSUs (transaction code M) and the withholding for taxes (transaction code F). The conversion had no cash exercise price ($0.00 per share), consistent with RSU treatment.

Key Details

  • Transaction date: April 2, 2026; Form 4 filed April 3, 2026 (timely).
  • Acquired: 11,518 shares via RSU conversion (M) at $0.00 per share.
  • Withheld/disposed for taxes: 3,992 shares at $0.07 per share, total $276 (F).
  • Net shares retained: 7,526 (11,518 − 3,992).
  • Shares held in trust: some shares are noted as held in trust for the reporting person’s spouse and children; the reporting person disclaims beneficial ownership for those (footnote).
  • Filings and footnotes: RSUs convert 1-for-1 (F1); withholding reflects tax obligations (F2); grant date was April 2, 2024 and remaining portions of that grant vest in two equal installments on Oct 2, 2026 and Apr 2, 2027 (F4).
  • The report identifies Levine as a 10% owner; this is an ownership disclosure rather than an open-market buy/sell initiated for trading.

Context

  • This was RSU vesting/conversion, not an open-market purchase or discretionary sale. The withholding of shares to cover taxes is a routine administrative step and is coded as a disposition (F).
  • For retail investors: such vesting events are routine compensation-related transactions and do not necessarily signal an intentional buy/sell decision by the insider.